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1. Introduction
Embryology has a long history. Since early last century, many studies focused on 
revealing the mechanism of the fertilization and embryo formation and develop-
ment, which formed a branch discipline of biology science, that is, embryology. 
Embryology is a vast discipline concerned with the study of embryogenesis, and 
it is the branch of biology that studies the prenatal development of gametes, 
fertilization, and development of embryos and fetuses. Additionally, embryology 
encompasses the study of congenital disorders that occur before birth, known 
as teratology [1, 2]. Findings in embryology have helped in the understanding of 
congenital abnormalities and developing assisted reproduction procedures.
To date, embryology has been enriched and developed greatly in the terms of its 
contents and forms. It not only includes oogenesis, spermiogenesis, embryogenesis, 
implantation, and fetal formation mechanism, but also involves pharmacology, 
basic scientific research, and regenerative medicine. Although this subject has been 
studied for more than a century, it is still a pioneering field with many alternative 
aspects such as embryonic stem cell, somatic cell cloning, and many novel discover-
ies that appear continuously. Particularly, some novel embryo biotechnologies have 
initiated a new era in the fields of medical science and agriculture owing to their 
enormous biomedical and commercial potential.
In the last four decades, the assisted reproductive technology (ART) has created 
some new observations and novel discoveries in the early stage of embryogenesis, 
especially in preimplantation from gametogenesis to blastocyst embryo formation 
in vitro (Figure 1).
Thus, this book contains some novel discoveries and theories on the embryology 
field in last the decade.
The key technique of the assisted reproductive technology is in vitro fertilization 
(IVF). Since this technique’s creation, the current developed methods have been 
widely used for the treatment of infertile couples to make them realize their dream to 
Figure 1. 
Human embryogenesis from oocyte to blastocyst stage during preimplantation.
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have a baby. Currently, these technologies mainly contain in vitro fertilization (IVF) 
and its related procedures—intracytoplasmic sperm injection (ICSI), frozen embryo 
transfer (FET), and preimplantation genetic testing (PGT) for aneuploidies (PGT-A, 
previously known as PGS), for monogenic/single-gene defects (PGT-M, previously 
known as PGD), and for chromosomal structural rearrangements (PGT-SR, previ-
ously known as PGD Screen (PGS)). [Note: New PGT nomenclature announced 
by the International Committee Monitoring Assisted Reproductive Technologies 
(ICMART) in collaboration with the American Society for Reproductive Medicine 
(ASRM), European Society of Human Reproduction and Embryology (ESHRE), 
and other professional medical societies, 2018] [3]. So far, more than 10 million IVF/
ICSI and frozen embryo transfer babies have been born throughout the world. This 
technique indeed gives many infertile families to bring happy life. Although this 
technology has been widely used in human infertile treatment and animal industry, it 
also faces some problems which need to be resolved, such as low embryo development 
rate, low pregnant rate, as well as birth baby health. Thus, some continuous improve-
ments on this technology have been happening now. Firstly, in order to obtain good 
quality eggs, ovarian stimulation needs to use some high-quality medicines such as 
gonadotropins, including human chorionic gonadotropin (hCG), which is the most 
important reproductive hormone for embryogenesis and embryo development and 
implantation in the uterus [4–6]. Thus, we should concern the total hCG protein 
content varied from batch to batch and a large number of contaminant urinary 
proteins identified in all analyzed samples except for the recombinant product. The 
good quality hCG application will improve embryo quality and pregnant rate.
In vitro maturation (IVM) is a technique used to induce in vitro maturation of 
immature oocytes collected from ovarian follicles without any medication stimula-
tion. In a routine IVF practice, several kinds of gonadotropins are used to produce 
more mature eggs for fertilization every egg retrieval cycle. This procedure is 
widely used in most of the IVF centers, but the application of these drugs obviously 
increases fertility treatment cost, and patients also suffer many times from drug 
injections. In IVF practice, another pathway is oocyte in vitro maturation; that 
is, without ovarian stimulation, immature oocytes are retrieved from ovary and 
conducted for maturation under the laboratory condition for about 24 h in vitro, 
subsequent for normal insemination. Currently this technology has achieved some 
success, but it needs to be further improved to obtain a higher pregnant rate. Thus, 
IVM application significantly reduces IVF cost, patient emotional address and side 
effects, and frequent hospital visits [7].
At beginning, IVM technique was designed as an alternative to conventional 
IVF for minimizing the risk of the ovarian hyperstimulation syndrome (OHSS) in 
patients with the polycystic ovarian syndrome (PCOS). As an effective treatment 
method, IVM can be used to treat patients with polycystic ovary syndrome, ovarian 
hyperresponsiveness, and hyporesponsiveness, as well as to preserve the fertility 
of cancer patients [8]. This technology has been used worldwide for the birth of 
thousands of healthy babies. The improvement in clinical IVM technology mainly 
focuses on the IVM medium and the optimization of the culture environment and 
operation process. Recently many research groups have started to combine clinical 
application of IVM with a natural cycle or mild stimulation in IVF practice, espe-
cially for PCOS and age women. In particular, the combination of mild stimulation 
IVF with IVM is not only expected to become a viable alternative to current stan-
dard treatments, but may also become a potential option of first-line treatment.
After obtaining MII oocytes, a key technique is oocyte insemination with sperm 
including in vitro fertilization and intracytoplasmic sperm injection in order to 
obtain normal fertilized egg, that is, zygote. ICSI technique has greatly improved 
normal IVF fertilization failure and increased oocyte fertilization rate and solved 
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severe male infertility problem [9], which has made many infertile males realize 
their dream to have children in their family. However, some fertilization failures 
still appear on good quality oocytes. Thus, oocyte activation is also very important 
for fertilization. The incidence and etiology of total fertilization failure after ICSI 
have led embryologists to search new activation studies including physiology of 
oocyte activation, electrical properties of gametes’ membranes, and ion currents. 
It is very important that calcium oscillation is an essential process during oocyte 
activation. Many researches have shown that oocyte activation is triggered by sperm 
factor [10, 11]. Artificial oocyte activation (AOA) also imitates sperm factor func-
tion to stimulate oocyte activation for successful fertilization. Artificial activation 
can be induced by the use of electrical, mechanical, or chemical stimuli to elevate 
intracellular concentrations of calcium ions [12]. Thus, discussion on the effect of 
different AOA methods on the success and safety will help embryologists to improve 
fertilization rate and reduce fertilization failure accident.
As shown in Figure 1, after fertilization, the embryo experiences a series of 
events including the formation of the maternal and paternal pronuclei (2PN) on day 
1 and cleavage stage on day 1.5 to day 3, reaching the morula (compaction) on day 4 
and the blastocyst on day 5, until it arrives at the uterus, where it “hatches” from the 
zona pellucida to implant into the endometrium. During this period, some important 
findings are obtained from many IVF practices. Thus, understanding human and 
animal blastocyst formation and development and their physiology, morphology, 
and gene expression of blastocyst will help us to reveal the reason for high rate of 
embryo implantation failure. All these processes for embryonic development need 
neuroendocrine regulation. Neuroendocrine, an integration of the nervous system 
and endocrine system as its name implies, plays a critical role in the reproductive 
system. However, less progress has been made in the particular effects of neuro-
endocrine on embryo implantation. Despite these barriers, significant knowledge 
has been gained through recent studies and shows that neuroendocrine is tightly 
involved in embryo implantation. Therefore, the current state of knowledge about 
the impaction of neuroendocrine on embryo implantation could make us consider a 
potential strategy to get higher pregnancy rate after in vitro fertilization and embryo 
transfer (IVF-ET) in order to decrease recurrent implantation failure (RIF) possibil-
ity through modulating the neuroendocrine systems [13, 14].Another important 
branch in IVF practice is embryo cryopreservation. Embryo freezing technologies 
have widely been developed and used in human IVF practice and animal industry 
[15, 16]. In the last decade, the cryopreservation of reproductive cells including stem 
cells, embryos, gametes, tissues, and organs has become a routine work in many IVF 
centers and animal industry [17]. As the embryo freezing number increases, some 
new techniques for cryopreservation have been developed, especially oocyte and 
embryo vitrification, which have greatly improved oocyte and embryo survival rate 
after thawing or warming [16]. It is very interesting that a new “Theory About the 
Embryo-Cryo Treatment” has been formed. It should be considered that the method 
of cryopreservation is not only a technology for storing embryos but also a method 
of embryo treatment that can potentially improve the success rates in infertile 
couples. This theory believes that freezing and thawing process could activate 
endogenous survival and repair mechanisms in preimplantation embryos. We think 
that the embryonic thawing process induces low levels of stress, which results in 
hormesis and could repair mitochondrial damage and protein misfolding. Thus, this 
theory may explain the higher success rate of frozen-thawing embryo transfer than 
fresh embryo transfer for age women and the higher miscarriage case. Thus, the 
“treatment” effect of freezing an embryo may explain the higher success rates than 
fresh embryo transfer. The analysis of facts and suggestions should enable research-
ers to rethink the position of cryobiology in reproductive medicine.
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During the last couple of decades, the assisted reproductive technologies have 
become one of the fastest developing branches of medicine. Assisted reproductive 
technology has been widely used for the treatment of infertile couples to realize 
their dream to have a baby. However, many people are worried about ART baby 
health outcome. Although many reviews of ART effect on birth babies have been 
reported, it is very difficult to find a system data about ART outcome on sex ratio 
and frozen embryo transfer. Our study provides some detailed data about the effect 
of ART on human birth babies by two country IVF center data. The result showed 
that ART patient age is significantly older than normal delivered women; the 
gestation of fresh and frozen embryo transfer has the same as normal deliver baby 
gestation days, but multi-baby birth women have shorter gestation days; there is no 
significant difference on early birth between fresh embryo transfer single babies 
and normal delivered babies, but multi-babies have a higher early birth rate, and 
frozen embryo transfer has lower early birth rate; there is no significant difference 
between male and female babies although fresh embryo transfer looks like more 
male babies and frozen embryo transfer has more female babies; there is no signifi-
cant difference on the baby weight between ART singleton babies and normal deliv-
ered babies, but male baby weight is more than female babies, and multi-baby birth 
weights have significant lower singletons, while frozen embryo transfer babies have 
significant heavier birth weight than fresh embryo transfer. These results showed 
that the singleton with ART treatment does not have any significant difference from 
normal single babies on gestation days, early birth rate, and baby birth weight, 
but multi-baby birth often has high early birth rate with shorter gestation day and 
lower birth weight. The frozen embryo transfer may significantly reduce early birth 
rate. Thus, frozen embryo transfer may be recommended as a very healthy strategy 
in ART.
In fine, some new technologies, theories, and methods in early embryogenesis 
from ovarian stimulation to final ART outcome have been developed in the last 
decade. The systemic understanding of these new knowledge containing some basic 
theories and technologies will be helpful for animal scientists and human clinical 
physicians and embryologists to improve their ART outcome.
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